{"entity":{"type":"insider","cik":"0001415537","url":"/insider/0001415537","json_url":"/insider/0001415537.json","name":"Iwicki Mark T","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":17,"first":"2015-08-11","last":"2025-10-24","span_basis":"filed_date"},"name_variants":[{"name":"Iwicki Mark T","source":"filing","n_filings":17,"first_seen":"2015-08-11","last_seen":"2025-10-24"}],"transactions":[{"id":4588234,"accession":"0001415537-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415537-25-000004","line_url":"/filing/0001415537-25-000004#line-1","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":154894.0,"shares_display":"154,894","price_per_share":0.81,"price_display":"0.81","price_state":"stated","total_value":125464.14,"total_display":"125,464.14","total_whole":"125,464","shares_owned_after":103540.0,"shares_owned_after_display":"103,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-23","filed_date":"2025-10-24","scope":"insider"},{"id":4146768,"accession":"0001415889-25-018317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-018317","line_url":"/filing/0001415889-25-018317#line-1","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13227.0,"shares_display":"13,227","price_per_share":4.01,"price_display":"4.01","price_state":"stated","total_value":53040.27,"total_display":"53,040.27","total_whole":"53,040","shares_owned_after":258433.0,"shares_owned_after_display":"258,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-24","filed_date":"2025-06-26","scope":"insider"},{"id":9223956,"accession":"0001104659-25-056986","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-056986","line_url":"/filing/0001104659-25-056986#line-1","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10866.0,"shares_display":"10,866","price_per_share":3.74,"price_display":"3.74","price_state":"stated","total_value":40638.84,"total_display":"40,638.84","total_whole":"40,639","shares_owned_after":269210.0,"shares_owned_after_display":"269,210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-05","scope":"insider"},{"id":4281351,"accession":"0001415889-25-015677","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-015677","line_url":"/filing/0001415889-25-015677#line-1","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10866.0,"shares_display":"10,866","price_per_share":3.74,"price_display":"3.74","price_state":"stated","total_value":40638.84,"total_display":"40,638.84","total_whole":"40,639","shares_owned_after":269210.0,"shares_owned_after_display":"269,210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-04","scope":"insider"},{"id":5079071,"accession":"0001415889-25-001060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-001060","line_url":"/filing/0001415889-25-001060#line-2","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5779.0,"shares_display":"5,779","price_per_share":7.63,"price_display":"7.63","price_state":"stated","total_value":44093.77,"total_display":"44,093.77","total_whole":"44,094","shares_owned_after":280076.0,"shares_owned_after_display":"280,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-07","scope":"insider"},{"id":2711075,"accession":"0001415889-24-018374","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-018374","line_url":"/filing/0001415889-24-018374#line-1","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15168.0,"shares_display":"15,168","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":72048.0,"total_display":"72,048.00","total_whole":"72,048","shares_owned_after":263755.0,"shares_owned_after_display":"263,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-26","filed_date":"2024-06-27","scope":"insider"},{"id":2602827,"accession":"0001415889-24-015222","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-015222","line_url":"/filing/0001415889-24-015222#line-1","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7392.0,"shares_display":"7,392","price_per_share":6.09,"price_display":"6.09","price_state":"stated","total_value":45017.28,"total_display":"45,017.28","total_whole":"45,017","shares_owned_after":278923.0,"shares_owned_after_display":"278,923","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-31","filed_date":"2024-06-03","scope":"insider"},{"id":2039274,"accession":"0001415889-24-000769","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-000769","line_url":"/filing/0001415889-24-000769#line-2","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4539.0,"shares_display":"4,539","price_per_share":6.73,"price_display":"6.73","price_state":"stated","total_value":30547.47,"total_display":"30,547.47","total_whole":"30,547","shares_owned_after":286315.0,"shares_owned_after_display":"286,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-05","scope":"insider"},{"id":8732264,"accession":"0001415889-23-000636","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-000636","line_url":"/filing/0001415889-23-000636#line-2","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":198.0,"shares_display":"198","price_per_share":28.54,"price_display":"28.54","price_state":"stated","total_value":5650.92,"total_display":"5,650.92","total_whole":"5,651","shares_owned_after":45966.0,"shares_owned_after_display":"45,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-06","scope":"insider"},{"id":6506078,"accession":"0001415889-22-010878","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-010878","line_url":"/filing/0001415889-22-010878#line-1","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":561.0,"shares_display":"561","price_per_share":6.52,"price_display":"6.52","price_state":"stated","total_value":3657.72,"total_display":"3,657.72","total_whole":"3,658","shares_owned_after":4464.0,"shares_owned_after_display":"4,464","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-26","filed_date":"2022-10-28","scope":"insider"},{"id":6558025,"accession":"0001415889-22-007059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-007059","line_url":"/filing/0001415889-22-007059#line-1","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7975.0,"shares_display":"7,975","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":2950.75,"total_display":"2,950.75","total_whole":"2,951","shares_owned_after":251183.0,"shares_owned_after_display":"251,183","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-27","filed_date":"2022-06-29","scope":"insider"},{"id":6904541,"accession":"0001415889-22-000402","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-000402","line_url":"/filing/0001415889-22-000402#line-1","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9518.0,"shares_display":"9,518","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":12373.4,"total_display":"12,373.40","total_whole":"12,373","shares_owned_after":259158.0,"shares_owned_after_display":"259,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-05","scope":"insider"},{"id":4501721,"accession":"0001415889-21-005009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-005009","line_url":"/filing/0001415889-21-005009#line-1","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27598.0,"shares_display":"27,598","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":49676.4,"total_display":"49,676.40","total_whole":"49,676","shares_owned_after":268676.0,"shares_owned_after_display":"268,676","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-26","filed_date":"2021-10-28","scope":"insider"},{"id":4754888,"accession":"0001415889-21-003256","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-003256","line_url":"/filing/0001415889-21-003256#line-1","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7586.0,"shares_display":"7,586","price_per_share":5.77,"price_display":"5.77","price_state":"stated","total_value":43771.22,"total_display":"43,771.22","total_whole":"43,771","shares_owned_after":296274.0,"shares_owned_after_display":"296,274","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-29","scope":"insider"},{"id":6282794,"accession":"0000899243-18-009609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-009609","line_url":"/filing/0000899243-18-009609#line-1","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"Pulmatrix, Inc.","issuer_ticker":"PULM","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":307000.0,"shares_display":"307,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":307000.0,"shares_owned_after_display":"307,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-03","filed_date":"2018-04-05","scope":"insider"},{"id":6593027,"accession":"0000899243-18-005465","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-005465","line_url":"/filing/0000899243-18-005465#line-1","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9375.0,"shares_display":"9,375","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":29375.0,"shares_owned_after_display":"29,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-26","filed_date":"2018-02-26","scope":"insider"},{"id":8477578,"accession":"0000899243-15-002781","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-15-002781","line_url":"/filing/0000899243-15-002781#line-1","is_derivative":false,"issuer_cik":"0001415537","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001415537","owner_cik":"0001415537","owner_name":"Iwicki Mark T","owner_display_name":"Iwicki Mark T","owner_url":"/insider/0001415537","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":320000.0,"total_display":"320,000.00","total_whole":"320,000","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-11","filed_date":"2015-08-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001479419","name":"KALA BIO, Inc.","url":"/issuer/0001479419","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","n_filings":14,"first_seen":"2021-06-29","last_seen":"2025-10-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001574235","name":"Pulmatrix, Inc.","url":"/issuer/0001574235","role":"Director","n_filings":1,"first_seen":"2018-04-05","last_seen":"2018-04-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001631650","name":"Aimmune Therapeutics, Inc.","url":"/issuer/0001631650","role":"Director","n_filings":2,"first_seen":"2015-08-11","last_seen":"2018-02-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001415537","retrieved_at":"2026-08-24T01:49:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}